Analytical Assesment of Fasting Blood Glucose and Glycated Hemoglobin (HbA1c) for Glycemic Status Classification among Adults Undergoing Routine Laboratory Examination in Duhok, Iraq

Authors

  • Zhiyar Nizar Saeed Awny Laboratory, Duhok, Kurdistan Region, Iraq.
  • Pasar Nizar Saeed Awny Laboratory, Duhok, Kurdistan Region, Iraq.
  • Zana Sabri Qasim College of Pharmacy, Nawroz University, Duhok, Kurdistan Region, Iraq
  • Darya Salih Hussein College of Pharmacy, Cihan University-Duhok, Duhok, Kurdistan Region, Iraq

DOI:

https://doi.org/10.29303/aca.v9i2.323

Keywords:

age; cross-sectional study; diabetes mellitus; Duhok; HbA1c; prediabetes

Abstract

The biochemical assessment of glucose metabolism is essential for the early identification of metabolic disorders, particularly prediabetes and diabetes mellitus. Fasting blood glucose (FBS) and glycated hemoglobin (HbA1c) provide complementary biochemical information for evaluating glycemic status through routine clinical chemistry analysis. This study investigated the prevalence of abnormal glycemic status among adults and examined its association with sociodemographic characteristics using complementary analytical methods. A cross-sectional study was conducted involving 600 adults aged ≥18 years undergoing routine laboratory examinations at Dr. Awny Laboratory in Duhok City, Kurdistan Region of Iraq, between September and December 2025. FBS concentrations were determined using a Cobas Pure c303 clinical chemistry analyzer, whereas HbA1c levels were quantified using high-performance liquid chromatography (HPLC). Glycemic status was classified according to the American Diabetes Association criteria, and the data were analyzed using descriptive statistics, binary logistic regression, one-way analysis of variance, and chi-square tests. Of the 600 participants, 434 (72.3%) exhibited normal glycemic status, 127 (21.2%) had prediabetes, and 39 (6.5%) had diabetes mellitus, corresponding to an overall abnormal glycemic prevalence of 27.7%. Mean age increased significantly across the normal, prediabetes, and diabetes groups (25.3 ± 4.8, 37.5 ± 6.2, and 50.1 ± 7.1 years, respectively; p < 0.001). Age was independently associated with abnormal glycemic status (adjusted OR = 1.07, 95% CI: 1.06–1.09; p < 0.001), whereas gender showed no significant association. These findings demonstrate the practical relevance of automated biochemical glucose determination and HPLC-based HbA1c quantification for the biochemical assessment of glycemic abnormalities in routine laboratory settings. The integration of these analytical approaches provides complementary information for identifying individuals with impaired glucose regulation and highlights the importance of age-stratified biochemical screening for the early detection of metabolic disorders.

Downloads

Download data is not yet available.

References

[1] Alam, U., Asghar, O., Azmi, S., & Malik, R. A. (2014). General aspects of diabetes mellitus. Handbook of Clinical Neurology, 126, 211-222. https://doi.org/10.1016/B978-0-444-53480-4.00015-1

[2] Sacks, D. B., Arnold, M., Bakris, G. L., et al. (2023). Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care, 46(10), e151-e199. https://doi.org/10.2337/dci23-0036

[3] DeFronzo, R. A. (2009). From the triumvirate to the ominous octet: A new paradigm for the treatment of type 2 diabetes mellitus. Diabetes, 58(4), 773-795. https://doi.org/10.2337/db09-9028

[4] Echouffo-Tcheugui, J. B., & Selvin, E. (2021). Prediabetes and what it means: The epidemiological evidence. Annual Review of Public Health, 42, 59-77. https://doi.org/10.1146/annurev-publhealth-090419-102644

[5] American Diabetes Association Professional Practice Committee. (2026). Standards of Care in Diabetes-2026: Diagnostic criteria and confirmation of diagnosis. Diabetes Care, 49(Suppl. 1), S27-S49. https://doi.org/10.2337/dc26-S002

[6] NCD Risk Factor Collaboration (NCD-RisC). (2023). Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c. Nature Medicine, 29(11), 2885-2901. https://doi.org/10.1038/s41591-023-02610-2

[7] Ong, K. L., Stafford, L. K., McLaughlin, S. A., et al. (2023). Global, regional, and national burden of diabetes from 1990 to 2021, with projections to 2050: A systematic analysis for the Global Burden of Disease Study 2021. The Lancet, 402(10397), 203-234. https://doi.org/10.1016/S0140-6736(23)01301-6

[8] Jasim, O. H., Mahmood, M. M., & Ad'hiah, A. H. (2022). Prevalence and prediction of prediabetes among apparently healthy Iraqis from Baghdad. Health Education and Health Promotion, 10(2), 411-421.

[9] Abdulrahman Aga, I. M. T., & Al-Naemi, A. H. (2025). Prevalence of type 2 diabetes mellitus and pre-diabetes in Mosul City, Northern Iraq: Changes over 20 years. Annals of the College of Medicine, Mosul, 47(1), 13-20. https://doi.org/10.33899/mmed.2025.157150.1303

[10] Pourhoseingholi, M. A., Vahedi, M., & Rahimzadeh, M. (2013). Sample size calculation in medical studies. Gastroenterology and Hepatology from Bed to Bench, 6(1), 14-17.

[11] Lu, J., He, J., Li, M., et al. (2019). Predictive value of fasting glucose, postload glucose, and hemoglobin A1c on risk of diabetes and complications in Chinese adults. Diabetes Care, 42(8), 1539-1548. https://doi.org/10.2337/dc18-1390

[12] Aamir, A. H., Ul-Haq, Z., Mahar, S. A., et al. (2019). Diabetes Prevalence Survey of Pakistan: Prevalence of type 2 diabetes mellitus and prediabetes using HbA1c. BMJ Open, 9(2), e025300. https://doi.org/10.1136/bmjopen-2018-025300

[13] Aldossari, K. K., Aldiab, A., Al-Zahrani, J. M., et al. (2018). Prevalence of prediabetes, diabetes, and associated risk factors among males in Saudi Arabia: A population-based survey. Journal of Diabetes Research, 2018, 2194604. https://doi.org/10.1155/2018/2194604

[14] Ajayi, I. O., Balogun, W. O., Olopade, O. B., et al. (2023). Prevalence of haemoglobin A1c-based dysglycaemia among adult community dwellers in selected states in Nigeria: A descriptive cross-sectional study. Frontiers in Endocrinology, 14, 1192491. https://doi.org/10.3389/fendo.2023.1192491

[15] World Health Organization. (2011). Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus: Abbreviated report of a WHO consultation. World Health Organization.

[16] Cowie, C. C., Rust, K. F., Byrd-Holt, D. D., et al. (2010). Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006. Diabetes Care, 33(3), 562-568. https://doi.org/10.2337/dc09-1524

[17] Selvin, E., Steffes, M. W., Zhu, H., et al. (2010). Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. New England Journal of Medicine, 362(9), 800-811. https://doi.org/10.1056/NEJMoa0908359

[18] von Elm, E., Altman, D. G., Egger, M., et al. (2008). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Journal of Clinical Epidemiology, 61(4), 344-349. https://doi.org/10.1016/j.jclinepi.2007.11.008

Additional Files

Published

2026-11-05

How to Cite

Nizar Saeed, Z., Nizar Saeed, P., Sabri Qasim, Z., & Salih Hussein, D. (2026). Analytical Assesment of Fasting Blood Glucose and Glycated Hemoglobin (HbA1c) for Glycemic Status Classification among Adults Undergoing Routine Laboratory Examination in Duhok, Iraq. Acta Chimica Asiana, 9(2), 900–909. https://doi.org/10.29303/aca.v9i2.323

Issue

Section

Articles

Similar Articles

<< < 2 3 4 5 6 7 8 9 10 11 > >> 

You may also start an advanced similarity search for this article.